Crossmark

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry

Crossref DOI link: https://doi.org/10.1080/07853890.2021.1893897

Published Online: 2021-04-05

Published Print: 2021-01

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Pope, Marita Knudsen

Atar, Dan https://orcid.org/0000-0003-1513-8793
Svilaas, Arne

Hole, Torstein

Nielsen, Jørn Dalsgaard

Hintze, Ulrik

Crisby, Milita

Raatikainen, Pekka

Airaksinen, K. E. Juhani https://orcid.org/0000-0002-0193-568X
Virdone, Saverio

Pieper, Karen

Kayani, Gloria

Le Heuzey, Jean-Yves

Steffel, Jan

Stepinska, Janina

Bassand, Jean-Pierre

Camm, A. John

,
License Information

Version of Record valid from 2021-01-01
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iann20

Publication History

Received: 2020-10-14

Revised: 2021-02-09

Accepted: 2021-02-16

Published: 2021-04-05

Document is current

Any future updates will be listed below